Tobacco smoking is the leading cause of preventable disease and death in Australia today. Smoking increases blood pressure, reduces blood oxygen levels and damages blood vessels, heightening the risk of plaques and clots.
People who smoke are at increased risk for the development and progression of chronic kidney disease (CKD) – and that risk increases with greater lifetime exposure to smoking (Hallan and Orth 2011; Yacoub et al. 2010). Smoking contributes to negative outcomes for people with kidney transplants (Mercado and Jaimes 2007). Smoking also contributes to the development of other chronic diseases closely linked to CKD, including cardiovascular disease and type 2 diabetes (Briganti et al. 2002).
Australia’s smoking rate has fallen over the past 40 years, largely attributable to public health strategies. However, the proportion of people continuing to smoke is still concerning, particularly in some population groups such as Aboriginal and Torres Strait Islander people, and people living in low socioeconomic areas (Greenhalgh et al. 2022).
In 2019, based on results from the National Drug Strategy Household Survey:
- 11% of people aged 14 and over smoked daily (males 12%, females 9.9%)
- men aged 40–49 had the highest proportion of current daily smokers (18%), while the highest proportion among women were aged 50–59 (15%)
- after adjusting for different population age structures over time, the proportion of males aged 14 and over who smoked daily fell from 21% in 2001 to 12% in 2019, with the proportion for females falling from 18% in 2001 to 9.9% in 2019 (Figure 1)
- daily smoking rates among males aged 15–24 fell from 21% in 2001 to 8.5% in 2019, and among females aged 15–24 from 20% in 2001 to 6.4% in 2019 (AIHW 2022).
Figure 1: Tobacco smoking status, people aged 14 and over, 2001 to 2019